EUVIMEDEUVIMED entdecken
Crossref

Glycogen Synthase Kinase-3β (GSK-3β) is a Critical Factor in Intracellular Signaling Pathways in Acute Lymphoblastic Leukemia

Cristian Fabian Layton Tovar

Haematology International Journal · 2018

DOI: 10.23880/hij-16000114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Haematology International Journal, 2018. Verfasst von Cristian Fabian Layton Tovar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lymphoblastic leukemia (ALL) is a common hematologic malignancy in children, teenagers, and young adults.The ALL development is a complex process, it includes the aberrant gene expression and the presence of chromosomal translocations.Chromosomal rearrangement have incidence in the cell maturation, proliferation and survival process.The treatment of ALL has shown high rates of effectiveness; however, the expression of biomarkers associated with the activation of cell signaling pathways is crucial to establish the prognosis of the disease.Glycogen synthase kinase-3β (GSK-3β) is a member of the serine/tyrosine kinase family with an important role in intracellular pathways signal; the GSK-3β transposition has been associated with changes in the transcriptional activity of nuclear factor kappa B (NF-kB) in blast cells.Nonetheless, others intracellular signaling pathways associated with the GSK-3β activity should participate in the ALL development.

Zitieren

APA

Tovar, C. F. L. (2018). Glycogen Synthase Kinase-3β (GSK-3β) is a Critical Factor in Intracellular Signaling Pathways in Acute Lymphoblastic Leukemia. Haematology International Journal. https://doi.org/10.23880/hij-16000114

Vancouver

Tovar CFL. Glycogen Synthase Kinase-3β (GSK-3β) is a Critical Factor in Intracellular Signaling Pathways in Acute Lymphoblastic Leukemia. Haematology International Journal. 2018. doi:10.23880/hij-16000114

BibTeX
@article{Tovar2018,
  author = {Tovar, Cristian Fabian Layton},
  title = {Glycogen Synthase Kinase-3β (GSK-3β) is a Critical Factor in Intracellular Signaling Pathways in Acute Lymphoblastic Leukemia},
  journal = {Haematology International Journal},
  year = {2018},
  doi = {10.23880/hij-16000114}
}
Kostenlos starten →